LUO Wenjuan, ZENG Jihong, YANG Bi. Research progress on orthokeratology lenses in the prevention and control of myopia in children[J]. Journal of Clinical Medicine in Practice, 2024, 28(20): 144-148. DOI: 10.7619/jcmp.20242605
Citation: LUO Wenjuan, ZENG Jihong, YANG Bi. Research progress on orthokeratology lenses in the prevention and control of myopia in children[J]. Journal of Clinical Medicine in Practice, 2024, 28(20): 144-148. DOI: 10.7619/jcmp.20242605

Research progress on orthokeratology lenses in the prevention and control of myopia in children

More Information
  • Received Date: June 19, 2024
  • Revised Date: September 10, 2024
  • Myopia in China shows a trend of high incidence, younger age of onset and severe degree. Childhood is the golden age of myopia management, and the prevention and control of myopia in children has gradually become the focus of public health issues. Orthokeratology has become the mainstream treatment regimen for controlling the development of myopia. This paper summarized the research progress of orthokeratology lens in the prevention and control of myopia in children from three aspects: the principle, function and safety of orthokeratology lens in the correction of myopia in children, and the influencing factors of application effect so as to provide scientific basis for clinical diagnosis and treatment and myopia prevention and control.

  • [1]
    中华预防医学会公共卫生眼科分会. 儿童青少年近视防控公共卫生策略分期专家共识(2022)[J]. 中华预防医学杂志, 2023, 57(6): 806-814. doi: 10.3760/cma.j.cn112150-20221002-00955
    [2]
    中华预防医学会公共卫生眼科分会, 北京预防医学会公共卫生眼科学专委会. 关于加强儿童青少年近视防控用眼行为干预的倡议及实施方法共识(2023)[J]. 中华实验眼科杂志, 2023, 41(4): 297-302. doi: 10.3760/cma.j.cn115989-20230102-00002
    [3]
    丁雯芝, 荆丽丽, 杜显丽. 青少年近视眼患者配戴角膜塑形镜后角膜透明度的变化分析[J]. 中华眼科杂志, 2019, 55(6): 435-441. doi: 10.3760/cma.j.issn.0412-4081.2019.06.006
    [4]
    国际角膜塑形学会亚洲分会. 中国角膜塑形用硬性透气接触镜验配管理专家共识(2016年)[J]. 中华眼科杂志, 2016, 52(5): 325-327. doi: 10.3760/cma.j.issn.0412-4081.2016.05.002
    [5]
    桑慧颖, 张鑫. 角膜塑形术矫正近视的疗效观察及护理干预[J]. 实用临床医药杂志, 2014, 18(6): 98-100. doi: 10.7619/jcmp.201406035
    [6]
    ATCHISON D A, JONES C E, SCHMID K L, et al. Eye shape in emmetropia and myopia[J]. Invest Ophthalmol Vis Sci, 2004, 45(10): 3380-3386. doi: 10.1167/iovs.04-0292
    [7]
    雷先明, 乔岗, 谢俪君, 等. 高度屈光参差近视患者眼轴长度与黄斑形态关系研究[J]. 眼科新进展, 2022, 42(10): 799-801.
    [8]
    中华医学会眼科学分会眼视光学组. 近视管理白皮书(2022)[J]. 中华眼视光学与视觉科学杂志, 2022, 24(9): 641-648. doi: 10.3760/cma.j.cn115909-20220812-00321
    [9]
    LIPSON M J. The role of orthokeratology in myopia management[J]. Eye Contact Lens, 2022, 48(5): 189-193. doi: 10.1097/ICL.0000000000000890
    [10]
    谷峰, 徐艳春, 张福生, 等. 近视青少年配戴角膜塑形镜前后调节参数变化[J]. 中华眼视光学与视觉科学杂志, 2021, 23(3): 199-204. doi: 10.3760/cma.j.cn115909-20200830-00347
    [11]
    《眼轴长度在近视防控管理中的应用专家共识》专家组, 何鲜桂, 许迅. 眼轴长度在近视防控管理中的应用专家共识(2023)[J]. 中华实验眼科杂志, 2024, 42(1): 1-11.
    [12]
    中华医学会眼科学分会眼视光学组, 中国医师协会眼科医师分会眼视光学专业委员会, 中国非公立医疗机构协会眼科专业委员会眼视光学组, 等. 角膜塑形镜验配流程专家共识(2021)[J]. 中华眼视光学与视觉科学杂志, 2021, 23(1): 1-5. doi: 10.3760/cma.j.cn115909-20201201-00464
    [13]
    赵文辰, 何鲜桂, 许迅. 角膜塑形镜临床应用的安全性研究进展[J]. 中华眼视光学与视觉科学杂志, 2022, 24(3): 235-240. doi: 10.3760/cma.j.cn115909-20200908-00360
    [14]
    王智群, 张阳, 孙旭光. 2007至2016年儿童感染性角膜炎病原学分析[J]. 中华眼科杂志, 2022, 58(6): 433-440. doi: 10.3760/cma.j.cn112142-20210809-00372
    [15]
    COPE J R, COLLIER S A, SCHEIN O D, et al. Acanthamoeba keratitis among rigid gas permeable contact lens wearers in the United States, 2005 through 2011[J]. Ophthalmology, 2016, 123(7): 1435-1441. doi: 10.1016/j.ophtha.2016.03.039
    [16]
    HSU C C. Dendrite-like anterior stromal keratitis coinfected with Acanthamoeba and Pseudomonas in an orthokeratology contact lens wearer[J]. J Ophthalmol, 2019, 9(2): 131-133.
    [17]
    苗春旭, 徐昕涌, 张会. 儿童夜戴角膜塑形镜角膜并发症分析[J]. 中华眼科杂志, 2017, 53(3): 198-202. doi: 10.3760/cma.j.issn.0412-4081.2017.03.010
    [18]
    王俞方, 夏世刚, 罗洁, 等. 长期配戴硬性角膜接触镜对泪膜稳定性的影响[J]. 中南医学科学杂志, 2015, 43(1): 63-66, 69.
    [19]
    CHEUNG S W, CHO P. Does a two-year period of orthokeratology lead to changes in the endothelial morphology of children[J]. Cont Lens Anterior Eye, 2018, 41(2): 214-218. doi: 10.1016/j.clae.2017.10.006
    [20]
    LIU Y M, XIE P Y. The safety of orthokeratology: a systematic review[J]. Eye Contact Lens, 2016, 42(1): 35-42. doi: 10.1097/ICL.0000000000000219
    [21]
    KONG Q H, GUO J, ZHOU J, et al. Factors determining effective orthokeratology treatment for controlling juvenile myopia progression[J]. Iran J Public Health, 2017, 46(9): 1217-1222.
    [22]
    LAM A K C, HON Y, LEUNG S Y Y, et al. Association between long-term orthokeratology responses and corneal biomechanics[J]. Sci Rep, 2019, 9(1): 12566. doi: 10.1038/s41598-019-49041-z
    [23]
    TARUTTA E P, VERZHANSKAYA T Y. Stabilizing effect of orthokeratology lenses (ten-year follow-up results)[J]. Vestn Oftalmol, 2017, 133(1): 49-54. doi: 10.17116/oftalma2017133149-54
    [24]
    CHARM J, CHO P. High myopia-partial reduction ortho-k: a 2-year randomized study[J]. Optom Vis Sci, 2013, 90(6): 530-539. doi: 10.1097/OPX.0b013e318293657d
    [25]
    KAKITA T, HIRAOKA T, OSHIKA T. Influence of overnight orthokeratology on axial elongation in childhood myopia[J]. Invest Ophthalmol Vis Sci, 2011, 52(5): 2170-2174. doi: 10.1167/iovs.10-5485
    [26]
    CHO P, CHEUNG S W. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial[J]. Invest Ophthalmol Vis Sci, 2012, 53(11): 7077-7085. doi: 10.1167/iovs.12-10565
    [27]
    谢静, 冯运红, 金守梅, 等. 角膜塑形镜对青少年近视发展的影响因素回归分析[J]. 国际眼科杂志, 2015, 15(5): 872-874.
    [28]
    WANG B J, NAIDU R K, QU X M. Factors related to axial length elongation and myopia progression in orthokeratology practice[J]. PLoS One, 2017, 12(4): e0175913. doi: 10.1371/journal.pone.0175913
    [29]
    SANTODOMINGO-RUBIDO J, VILLA-COLLAR C, GILMARTIN B, et al. Factors preventing myopia progression with orthokeratology correction[J]. Optom Vis Sci, 2013, 90(11): 1225-1236. doi: 10.1097/OPX.0000000000000034
    [30]
    朱梦钧, 冯浩雁, 瞿小妹. 不同光学设计角膜塑形镜控制近视进展的临床观察[J]. 中华眼视光学与视觉科学杂志, 2012, 14(2): 82-85, 89.
    [31]
    CHIA A, CHUA W H, CHEUNG Y B, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)[J]. Ophthalmology, 2012, 119(2): 347-354. doi: 10.1016/j.ophtha.2011.07.031
    [32]
    李发标, 孔祥斌, 麦雪燏, 等. 0.01%阿托品滴眼液联合角膜塑形镜在控制青少年近视进展中的效果[J]. 广西医科大学学报, 2019, 36(11): 1743-1746.
    [33]
    王静怡, 谷天瀑, 李双成, 等. 0.01%阿托品联合角膜塑形镜对于延缓青少年近视进展的Meta分析[J]. 中华眼视光学与视觉科学杂志, 2022, 24(1): 58-63.
    [34]
    刘莉, 邝国平, 彭婧利. 低浓度阿托品联合角膜塑形镜对青少年低中度近视患者治疗效果、泪膜功能及SF-36量表评分的影响[J]. 眼科新进展, 2021, 41(6): 575-578.
    [35]
    易姝, 余时智. 角膜塑形镜联合框架眼镜治疗青少年高度近视的临床观察[J]. 重庆医学, 2015, 44(26): 3649-3651. doi: 10.3969/j.issn.1671-8348.2015.26.016
    [36]
    郑丽绵, 刘婉君, 祁勇军, 等. 针刺联合角膜塑形镜防治儿童中低度近视的疗效观察[J]. 广州中医药大学学报, 2022, 39(11): 2598-2602.

Catalog

    Article views (108) PDF downloads (15) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return